Literature DB >> 12791438

High dose methadone and ventricular arrhythmias: a report of three cases.

Paul W Walker1, Douglas Klein, Leslie Kasza.   

Abstract

Three patients who developed torsades de pointes while receiving high dosages of oral methadone (>600mg/day) are presented. In all of the cases, drug interactions involving methadone and CYP3A4 isoenzyme system were possible. Two cases involve some previous cardiac impairment. The potential for toxic doses of methadone to cause ventricular arrhythmia is raised by these cases. Until further evidence is available it may be prudent to be vigilant for arrhythmias when high dosages of methadone (>600mg/day) are used, especially in patients on other drugs that interact with the CYP3A4 isoenzyme system, or with conditions that predispose to torsades de pointes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791438     DOI: 10.1016/S0304-3959(02)00461-X

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  17 in total

1.  Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients.

Authors:  Billy Huh; Chan-Hong Park
Journal:  Korean J Anesthesiol       Date:  2010-04-28

Review 2.  Methadone for treatment of cancer pain.

Authors:  John Bryson; Anoo Tamber; Dori Seccareccia; Camilla Zimmermann
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

3.  The opioid methadone induces a local anaesthetic-like inhibition of the cardiac Na⁺ channel, Na(v)1.5.

Authors:  V Schulze; C Stoetzer; A O O'Reilly; E Eberhardt; N Foadi; J Ahrens; F Wegner; A Lampert; J de la Roche; A Leffler
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

4.  A twist on torsade: a prolonged QT interval on methadone.

Authors:  Patricia Lamont; Susan C Hunt
Journal:  J Gen Intern Med       Date:  2006-11       Impact factor: 5.128

5.  QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.

Authors:  Judith A Martin; Anthony Campbell; Thomas Killip; Margaret Kotz; Mori J Krantz; Mary Jeanne Kreek; Brian A McCarroll; Davendra Mehta; J Thomas Payte; Barry Stimmel; Trusandra Taylor; Mark C P Haigney; Bonnie B Wilford
Journal:  J Addict Dis       Date:  2011-10

Review 6.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

7.  The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.

Authors:  Suresh Reddy; David Hui; Badi El Osta; Maxine de la Cruz; Paul Walker; J Lynn Palmer; Eduardo Bruera
Journal:  J Palliat Med       Date:  2010-01       Impact factor: 2.947

8.  The successful use of parenteral methadone in a patient with a prolonged QTc interval.

Authors:  Ryuichi Sekine; Eugenie A M T Obbens; Nessa Coyle; Charles E Inturrisi
Journal:  J Pain Symptom Manage       Date:  2007-07-05       Impact factor: 3.612

9.  Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem.

Authors:  W Victor R Vieweg; Mehrul Hasnain; Robert H Howland; Thomas Clausen; Jayanthi N Koneru; Christopher Kogut; Ericka L Breden Crouse; Jules C Hancox; Antony Fernandez; Ananda K Pandurangi
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

Review 10.  Methadone for Pain Management in Children with Cancer.

Authors:  Catherine Habashy; Erin Springer; Elizabeth A Hall; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2018-10       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.